Selected Titles

The latest videos and pictures

IMGM0506

Visual Report on the Introduction of “gynati” and “prequin”

actonib launch

Visual Report on the Introduction of Actonib and Its application in Dermatology

HY6A3173

Neurostyle Launch Event

nahaleh naraghi

Interview with Nahaleh Naraqi about Actoverco social responsibilities

__HA0603

Iran Pharma International Exhibition 2021

The latest news and articles

No Comments

Actoverco’s Contribution to the 40th Annual Congress of the Iranian Psychiatric Association

The 40th Annual Congress and the 23rd consecutive gathering of the Iranian Psychiatric Association took place from October 7 to 10 at Milad Hospital in Tehran, with active participation by ActoverCo.

No Comments

Introduction of Two Progesterone Drugs by Ati Pharmed at the Royan International Congress

Ati Pharmed Company introduced two of its products, Actogest and Dofamed, during a scientific symposium held at the 25th International Congress on Reproductive Medicine, the 20th Congress on Stem Cell Technology, and the 19th Midwifery Nursing Seminar at Royan Institute.

Nahale Naraghi honors Pharmacist Day with a special message!
No Comments

Nahaleh Naraqi honors Pharmacist Day with a special message!

Nahale Naraghi honors Pharmacist Day with a special message of gratitude, recognizing the essential role pharmacists play in advancing healthcare and supporting patient well-being

Nahaleh naraqi
No Comments

Nahaleh Naraqi’s congratulatory message on the occasion of Doctor’s Day

Nahale Naraghi honors National Doctors Day in Iran, coinciding with Avicenna’s birthday.

No Comments

Treatment and Reduction of Menopause Symptoms with New Drugs by “Atipharmed”

The pharmaceutical company “Atipharmed,” a subsidiary of the Actover Group, has introduced two new drugs to the national market, which are used for hormone therapy and alleviating post-menopause symptoms and issues.

actonib launch
No Comments

Production of the first drug approved by FDA for the treatment of severe alopecia areata in Iran

Baricitinib, marketed under the brand name Actonib, is the first FDA-approved medication for the treatment of moderate to severe alopecia areata in adults.

No Comments

Helping to Treat Neuropathic Pain and Anemia with an Iranian Supplement

In a ceremony attended by specialists in endocrinology, neurology, and nutrition, Nexus, a subsidiary of the Actoverco Pharmaceutical Group, unveiled its new product, “Neurostyle.”

No Comments

20th Congress of Gynecologists and Obstetricians

Enthusiastic Reception by Doctors and Specialists at the 20th Congress of Gynecologists and Obstetricians

Conferences and Exhibitions

MIL14860

Congress

__HA0325

2021 Pharmax Middle East Festival

2021 Pharmax Middle East Festival will be held from 19 to 21 October 2021 in Hall 5 (Nations)...
__HA0603

6th exhibition of Iran Pharma (IPH) opening ceremony

The opening ceremony of the 6th Iran Pharma Exhibition, the largest international specialized gathering of the country's pharmaceutical...
MIL14688

Introduction of new drugs